Evaluation of FPT-20 for the Treatment of Spermatogenesis and Semen Disorders

Summary

This clinical study aims to evaluate the efficacy and safety of a novel, natural-derived formulation (FPT-20) in supporting spermatogenesis. The investigation focuses on the formulation's potential to reduce inflammatory processes and support tissue regeneration within the testicular lobules, seminiferous tubule epithelium, and surrounding connective tissues. Additionally, the study assesses its ability to restore Leydig and Sertoli cell functions in patients with spermatogenic failure secondary to testicular inflammation.

Timeline

Start

2020-10-29

Primary completion

2026-05-20

Completion

2026-05-20

Drugs

Indications